Pharmaceutical Law & Industry Report® Index-Summary

DATA MINING

– N.H. ban on prescription data sales upheld (U.S., rev sought), 363; other states await ruling, 544; (rev den), 763
– Vt. ban on sale of prescription data by MDs upheld (D. Vt.), 495; firms denied injunction, 670

DaTSCAN

– Radiopharmaceutical agent, FDA panel recommends approval, 951

DEGARELIX

– Prostate cancer drug approved, 22

DELAWARE

– Medicaid, Omnicare to settle overcharging claims, 638

DEPAKOTE

– Epilepsy drug, FDA tells maker to pull misleading advertising, 159
– Generic approved, In Brief, 164

DETROL

– Bladder drug maker did not mislead PTO in prosecuting patent (D.N.J.), 461; discovery of marketing documents denied, 701

DIET DRUGS

See WEIGHT LOSS PRODUCTS AND PROGRAMS

DIGITEK

– Failure-to-warn claims may proceed (S.D. W.Va.), 993
– Heart attack death blamed on heart drug (E.D. Tex.), 502
– Product liability suits consolidated (Tex.), 944

DISCOUNTS

– Marketing claims settled (Pa. Commw. Ct.), 179
– Medicare, gap in coverage, drug makers promise discounts for some enrollees, 744
– N.Y. launches low-income drug card plan, 348
– PAP, In Brief, 978

DISTRICT OF COLUMBIA

– PBM disclosure law preempted (D.D.C.), 333

DORYX

– Acne drug maker seeks to block generic (D. N.J.), 336
– Antibiotic, generic ANDAs challenged as infringement, 14

DUAC

– Acne cream maker claims infringement by generic (D. Del.), 640

DURAGESIC

– Pain patch lots recalled, 46

DX-88

– Hereditary angioedema drug, FDA panel favors approval, 188